BiotechTube
Home/Investors/Topspin Partners

Topspin Partners

Biotech Investor · 2 portfolio companies

Portfolio
2
Combined Value
$229.8M
Focus Areas
7
Top Stage
Phase 3

Investment Focus

Neurodegenerative DiseasesNeurologyImmunologyRett SyndromeOncologyWilson DiseaseMetabolic Diseases

Portfolio Companies

CompanyValuation
Alector$229.8M
DepYmed—

Frequent Co-Investors

OrbiMed1 sharedDementia Discovery Fund1 sharedPolaris Partners1 sharedGoogle Ventures1 sharedMRL Ventures1 sharedMission Bay Capital1 shared